Industries > Pharma > Global Transplant Market Forecast 2019-2029

Global Transplant Market Forecast 2019-2029

Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users

PUBLISHED: 18 December 2018
PAGES: 184
PRODUCT CODE: PHA0346

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global transplant market will reach $29bn in 2019 and is estimated to grow at a CAGR of 9.9% from 2018- 2029. Visiongain estimated that Germany will hold 7.3% of the global transplant market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 82 tables and 55 figures– all unavailable elsewhere.

The 184-page report provides clear detailed insight into the transplant market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Transplant Market from 2019-2029

• Forecast of the Global Transplant market by Product:
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

• Forecast of the Global Transplant market by Application:
• Tissue Transplant: Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues
• Organ Transplant: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant

• Forecast of the Global Transplant market by End-user:
• Hospitals
• Transplant Centers
• Others

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada
• EU: Germany, France, United Kingdom, Italy, Spain and rest of EU
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa and rest of ROW

• Our study discusses the selected leading companies that are the major players in the transplant market:
• AbbVie, Inc.
• Arthrex, Inc.
• Medtronic
• Novartis AG
• Stryker
• Teva Pharmaceuticals
• Veloxis Pharmaceuticals
• Zimmer Biomet

• This study discusses the competitive landscape, including factors that drive and restrain the transplant market

• This report also provides the number organ transplant procedures from 2012-2027 in selected countries:
• The US
• Canada
• Germany
• UK
• France
• Italy
• Spain
• Japan
• China
• Brazil
• Mexico
• South Africa
• Russia

Global Transplant Market Forecast 2019-2029

Visiongain’s study is intended for anyone requiring commercial analyses for the transplant market. You find data, trends and predictions.

Buy our report today Global Transplant Market Forecast 2019-2029: Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Transplant Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Transplant Market Forecast 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category